Emergo Group Contact EMERGO

Health and Medical Devices News

Novartis conclui compra de participação majoritária da Nestlé na Alcon

HUENENBERG, Suíça--(BUSINESS WIRE)--A Novartis AG (NYSE: NVS) e a Nestlé S.A. anunciaram hoje a conclusão do processo de compra e venda de aproximadamente cento e cinquenta e seis milhões de ações da Alcon, Inc. (NYSE: ACL) por US$ 28,3 bilhões em espécie. A transação foi completada de acordo com um acordo entre a Nestlé e a Novartis, assinado em 6 de abril de 2008. Com a conclusão dessa transação, a Novartis é agora a acionista majoritária da Alcon e controla aproximadamente 77% das ações em ci


Novartis erwirbt Aktienmehrheit an Alcon von Nestlé

HÜNENBERG, Schweiz--(BUSINESS WIRE)--Novartis AG (NYSE: NVS) und Nestlé S.A. kündigten heute an, den Erwerb und Verkauf von ca. 156 Millionen Aktien an Alcon, Inc. (NYSE: ACL) für USD 28,3 Milliarden in bar abgeschlossen zu haben. Die Transaktion wurde einer zwischen Nestlé und Novartis am 6. April 2008 geschlossenen Vereinbarung folgend vollzogen. Novartis hat mit dem Abschluss dieser Transaktion Aktienmehrheit an Alcon und kontrolliert etwa 77 Prozent von Alcons ausgegebenen Aktien. Die fünf N


Novartis achève l’achat de la part majoritaire de Nestlé dans le capital d’Alcon

HUENENBERG, Suisse--(BUSINESS WIRE)--Novartis AG (NYSE : NVS) et Nestlé S.A. ont annoncé aujourd’hui qu’ils avaient terminé l’achat et la vente d’environ156 millions d’actions d’Alcon, Inc. (NYSE : ACL) pour un montant de 28,3 milliards de dollars au comptant. Cette transaction a été effectuée conformément à un accord conclu entre Nestlé et Novartis et exécuté le 6 avril 2008. Suite à la conclusion de cette transaction, Novartis est désormais l’actionnaire majoritaire d’Alcon et contrôle environ


El Comité de Directores Independientes (Independent Director Committee, IDC) de Alcon advierte el cierre de la adquisición por parte de Novartis de la participación de Nestlé en Alcon

HUENENBERG, Suiza--(BUSINESS WIRE)--El Comité de Directores Independientes advierte el cierre de la adquisición por parte de Novartis AG (“Novartis”) de la participación restante de Nestlé SA (“Nestlé”) en Alcon, Inc. (“Alcon”). La transacción, que aumenta la participación de Novartis en Alcon a aproximadamente el 77%, se concretó conforme al Acuerdo de compra y opción firmado por Nestlé y Novartis el 6 de abril de 2008. El cierre de la transacción Nestlé/Novartis es una medida esperada y no tie


Comitê independente de diretores da Alcon observa encerramento da aquisição da Novartis da participação da Nestlé na Alcon

HUENENBERG, Suíça--(BUSINESS WIRE)--O Comitê Independente de Diretores (o “IDC”) observa o encerramento da aquisição da Novartis AG (“Novartis”) da participação restante da Nestlé SA (“Nestlé”) na Alcon, Inc. (“Alcon”). A transação, que aumenta a participação da Novartis na Alcon para aproximadamente 77%, foi consumada em conformidade com o Acordo de Compra e Opção composto pela Nestlé e Novartis no dia 6 de abril de 2008. O encerramento da transação Nestlé/Novartis é um passo esperado e não imp


Le Comité des administrateurs indépendants d’Alcon note la clôture de l’acquisition de la participation de Nestlé dans Alcon par Novartis

HUENENBERG, Suisse--(BUSINESS WIRE)--Le Comité des administrateurs indépendants d’Alcon (l’« IDC ») note la clôture de l’acquisition de la participation résiduelle de Nestlé SA (« Nestlé ») dans Alcon (« Alcon ») par Novartis. La transaction, qui porte la participation de Novartis dans Alcon à environ 77 %, a été consommée en vertu de l’accord d’option d’achat d’actions conclu par Nestlé et Novartis le 6 avril 2008. La clôture de la transaction Nestlé/Novartis est une étape attendue et n’affecte


Biomagnetics Confirms Conference Call Hosted by President Clayton Hardman

SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP - News), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, confirms a scheduled conference call with the President and CEO of Biomagnetics Diagnostics Corp for Friday the 27th of August at 8:00 am PST and will conclude by 9:00am PST The conference call will begin at 8:00am PST. All interested parties can participate by dialing telephone number: 1-8


SonoSite Receives FDA Clearance for LumenVu Catheter Guidance System

BOTHELL, Wash.--(BUSINESS WIRE)--SonoSite Receives FDA Clearance For LumenVu Catheter Guidance System


Oklahoma Man Received Double Hand Transplant at Jewish Hospital Hand Care Center

LOUISVILLE, Ky.--(BUSINESS WIRE)--A team of surgeons from Kleinert Kutz and Associates and the University of Louisville performed a double hand transplant on an Edmond, Oklahoma man, Dr. Richard Edwards.


Research and Markets: Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/faf3ee/interventional_car) has announced the addition of GlobalData 's new report "Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering. Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 The Global Interventional Cardiology Devices Market is Expected to Grow by 5% o


GE Donates Web-based EMR to University of Texas Program

BARRINGTON, Ill.--(BUSINESS WIRE)--GE Healthcare is bringing today’s EMR technology to tomorrow’s practitioners by donating its latest platform to the University of Texas at Austin for educational use. The University’s Health Information Technology Summer Certificate Program just graduated its first class of 54 students at the end of July. These students used GE Centricity® Advance software in the University’s newly created Health Information Technology Learning Laboratory in the Clinical Educat


Research and Markets: Japan Surgical Equipment Market Outlook to 2016

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bc1410/japan_surgical_equ) has announced the addition of GlobalData's new report "Japan Surgical Equipment Market Outlook to 2016" to their offering. Japan Surgical Equipment Market Outlook to 2016 Summary Our medical devices report, Japan Surgical Equipment Market Outlook to 2016, provides key market data on the Japan Surgical Equipment market. The report provides value (USD million), volume (units) and av


Research and Markets: Medical Equipment Monthly Deals Analysis: M&A and Investments Trends 2010

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7cc1a2/medical_equipment) has announced the addition of GlobalData's new report "Medical Equipment Monthly Deals Analysis: M&A and Investments Trends 2010" to their offering. The Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010 report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment


International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy Program—The New Frontier of Medicine is Your Fat

SAN DIEGO--(BUSINESS WIRE)--Adipose Adult Stem Cell Therapy—The New Frontier of Medicine is Your Fat. “Your Fat Is Your Medicine Cabinet.”


Spectral Molecular Imaging, Inc. Announces Accelerated Timeline for its Early Melanoma Detection Product SkinSpect™

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Cascade Technologies, Inc. (OTCBB: CSDT) announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect™, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule. The device incorporates new advances in component technologies (optics, cameras, displays, embedded computers and software), as well as experience derived


Research and Markets: South Africa Surgical Equipment Market Outlook to 2016

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d6834e/south_africa_surgi) has announced the addition of GlobalData 's new report "South Africa Surgical Equipment Market Outlook to 2016" to their offering. Our medical devices report, South Africa Surgical Equipment Market Outlook to 2016, provides key market data on the South Africa Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each se


Research and Markets: Brazil Orthopedic Devices Market Outlook to 2016 - Key Market Data on Brazil's Orthopedic Device Market

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/510295/brazil_orthopedic) has announced the addition of GlobalData 's new report "Brazil Orthopedic Devices Market Outlook to 2016" to their offering. Our medical devices report, Brazil Orthopedic Devices Market Outlook to 2016 provides key market data on the Brazil orthopedic devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segmen


Research and Markets: Italy Opthalmic Devices Market Outlook to 2016 Provides Value (USD Million), Volume (Units) and Average Price (USD) Data

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/82abf7/italy_opthalmic_de) has announced the addition of GlobalData's new report "Italy Opthalmic Devices Market Outlook to 2016" to their offering. Our medical devices report, Italy Opthalmic Devices Market Outlook to 2016 provides key market data on the Italy ophthalmic devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment wit


Research and Markets: Israel Orthopedic Devices Market Outlook to 2016 - Key Market Data on the Israel Orthopedic Devices Market

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dbc532/israel_orthopedic) has announced the addition of GlobalData 's new report "Israel Orthopedic Devices Market Outlook to 2016" to their offering. Our medical equipment report, Israel Orthopedic Devices Market Outlook to 2016 provides key market data on the Israel orthopedic devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segm


Resumen: TomTec presenta en el congreso de la European Society of Cardiology en Estocolmo "4D MV-Assessment", la nueva solución 3D para un diagnóstico médico mejorado en el tratamiento de la válvula mitral

MUNICH, Alemania--(BUSINESS WIRE)--TomTec Imaging Systems GmbH ha anunciado el lanzamiento de su nuevo software 4D MV-Assessment© 2.0. El software 4D MV- Assessment combina la solidez de 2D con las ventajas de la ecocardiografía 3D para ofrecer al doctor una información y unos valores de diagnóstico sin precedentes para la válvula mitral. La tendencia a operar incluso a un paciente asintomático que sufre de regurgitación mitral es cada vez más importante. Con la utilización de los sets de datos